728 related articles for article (PubMed ID: 25771018)
1. High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment.
Yoshii Y; Furukawa T; Waki A; Okuyama H; Inoue M; Itoh M; Zhang MR; Wakizaka H; Sogawa C; Kiyono Y; Yoshii H; Fujibayashi Y; Saga T
Biomaterials; 2015 May; 51():278-289. PubMed ID: 25771018
[TBL] [Abstract][Full Text] [Related]
2. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
[TBL] [Abstract][Full Text] [Related]
3. Regorafenib as a potential adjuvant chemotherapy agent in disseminated small colon cancer: Drug selection outcome of a novel screening system using nanoimprinting 3-dimensional culture with HCT116-RFP cells.
Yoshii Y; Furukawa T; Aoyama H; Adachi N; Zhang MR; Wakizaka H; Fujibayashi Y; Saga T
Int J Oncol; 2016 Apr; 48(4):1477-84. PubMed ID: 26820693
[TBL] [Abstract][Full Text] [Related]
4. RNAi High-Throughput Screening of Single- and Multi-Cell-Type Tumor Spheroids: A Comprehensive Analysis in Two and Three Dimensions.
Fu J; Fernandez D; Ferrer M; Titus SA; Buehler E; Lal-Nag MA
SLAS Discov; 2017 Jun; 22(5):525-536. PubMed ID: 28277887
[TBL] [Abstract][Full Text] [Related]
5. Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids.
Senkowski W; Jarvius M; Rubin J; Lengqvist J; Gustafsson MG; Nygren P; Kultima K; Larsson R; Fryknäs M
Cell Chem Biol; 2016 Nov; 23(11):1428-1438. PubMed ID: 27984028
[TBL] [Abstract][Full Text] [Related]
6. The use of nanoimprinted scaffolds as 3D culture models to facilitate spontaneous tumor cell migration and well-regulated spheroid formation.
Yoshii Y; Waki A; Yoshida K; Kakezuka A; Kobayashi M; Namiki H; Kuroda Y; Kiyono Y; Yoshii H; Furukawa T; Asai T; Okazawa H; Gelovani JG; Fujibayashi Y
Biomaterials; 2011 Sep; 32(26):6052-8. PubMed ID: 21640378
[TBL] [Abstract][Full Text] [Related]
7. Thermo-responsive polymer aided spheroid culture in cryogel based platform for high throughput drug screening.
Sarkar J; Kumar A
Analyst; 2016 Apr; 141(8):2553-67. PubMed ID: 27027476
[TBL] [Abstract][Full Text] [Related]
8. 3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions.
Wenzel C; Riefke B; Gründemann S; Krebs A; Christian S; Prinz F; Osterland M; Golfier S; Räse S; Ansari N; Esner M; Bickle M; Pampaloni F; Mattheyer C; Stelzer EH; Parczyk K; Prechtl S; Steigemann P
Exp Cell Res; 2014 Apr; 323(1):131-143. PubMed ID: 24480576
[TBL] [Abstract][Full Text] [Related]
9. A Novel Multiparametric Drug-Scoring Method for High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer.
Cribbes S; Kessel S; McMenemy S; Qiu J; Chan LL
SLAS Discov; 2017 Jun; 22(5):547-557. PubMed ID: 28346096
[TBL] [Abstract][Full Text] [Related]
10. A polymer microstructure array for the formation, culturing, and high throughput drug screening of breast cancer spheroids.
Markovitz-Bishitz Y; Tauber Y; Afrimzon E; Zurgil N; Sobolev M; Shafran Y; Deutsch A; Howitz S; Deutsch M
Biomaterials; 2010 Nov; 31(32):8436-44. PubMed ID: 20692698
[TBL] [Abstract][Full Text] [Related]
11. 3-Dimensional culture systems for anti-cancer compound profiling and high-throughput screening reveal increases in EGFR inhibitor-mediated cytotoxicity compared to monolayer culture systems.
Howes AL; Richardson RD; Finlay D; Vuori K
PLoS One; 2014; 9(9):e108283. PubMed ID: 25247711
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer.
Imamura Y; Mukohara T; Shimono Y; Funakoshi Y; Chayahara N; Toyoda M; Kiyota N; Takao S; Kono S; Nakatsura T; Minami H
Oncol Rep; 2015 Apr; 33(4):1837-43. PubMed ID: 25634491
[TBL] [Abstract][Full Text] [Related]
13. A Novel High-Throughput 3D Screening System for EMT Inhibitors: A Pilot Screening Discovered the EMT Inhibitory Activity of CDK2 Inhibitor SU9516.
Arai K; Eguchi T; Rahman MM; Sakamoto R; Masuda N; Nakatsura T; Calderwood SK; Kozaki K; Itoh M
PLoS One; 2016; 11(9):e0162394. PubMed ID: 27622654
[TBL] [Abstract][Full Text] [Related]
14. Development of a magnetic 3D spheroid platform with potential application for high-throughput drug screening.
Guo WM; Loh XJ; Tan EY; Loo JS; Ho VH
Mol Pharm; 2014 Jul; 11(7):2182-9. PubMed ID: 24842574
[TBL] [Abstract][Full Text] [Related]
15. Establishment and Analysis of a 3D Co-Culture Spheroid Model of Pancreatic Adenocarcinoma for Application in Drug Discovery.
Meier-Hubberten JC; Sanderson MP
Methods Mol Biol; 2019; 1953():163-179. PubMed ID: 30912022
[TBL] [Abstract][Full Text] [Related]
16. The Microwell-mesh: A high-throughput 3D prostate cancer spheroid and drug-testing platform.
Mosaad EO; Chambers KF; Futrega K; Clements JA; Doran MR
Sci Rep; 2018 Jan; 8(1):253. PubMed ID: 29321576
[TBL] [Abstract][Full Text] [Related]
17. Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system.
Karlsson H; Fryknäs M; Larsson R; Nygren P
Exp Cell Res; 2012 Aug; 318(13):1577-85. PubMed ID: 22487097
[TBL] [Abstract][Full Text] [Related]
18. Exploring Drug Dosing Regimens In Vitro Using Real-Time 3D Spheroid Tumor Growth Assays.
Lal-Nag M; McGee L; Titus SA; Brimacombe K; Michael S; Sittampalam G; Ferrer M
SLAS Discov; 2017 Jun; 22(5):537-546. PubMed ID: 28298153
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of a human three-dimensional chondrosarcoma culture for in vitro drug testing.
Voissiere A; Jouberton E; Maubert E; Degoul F; Peyrode C; Chezal JM; Miot-Noirault É
PLoS One; 2017; 12(7):e0181340. PubMed ID: 28704566
[TBL] [Abstract][Full Text] [Related]
20. Using high throughput microtissue culture to study the difference in prostate cancer cell behavior and drug response in 2D and 3D co-cultures.
Mosaad E; Chambers K; Futrega K; Clements J; Doran MR
BMC Cancer; 2018 May; 18(1):592. PubMed ID: 29793440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
